XML 23 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Balance Sheet Details
9 Months Ended
Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Balance Sheet Account Details

4.  Balance Sheet Details

Restricted Cash

Restricted cash as of September 30, 2020 consists of: (i) a $0.5 million security deposit for the Company’s field force corporate credit card program; (ii) a $0.2 million standby letter of credit provided in lieu of a security deposit for the Watertown Lease (see Note 6); and (iii) a $40,000 security deposit for the Company’s corporate purchasing credit card. Restricted cash as of December 31, 2019 consists of a $0.9 million standby letter of credit provided in lieu of a security deposit for the San Diego Lease (see Note 6).

Inventory, Net

Inventory, net consisted of the following (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Raw materials

 

$

802

 

 

$

-

 

Work-in-process

 

 

2,340

 

 

 

1,505

 

Finished goods

 

 

4,132

 

 

 

706

 

Total inventory, net

 

$

7,274

 

 

$

2,211

 

 

As of September 30, 2020, inventory, net includes $2.1 million of the fair value step-up adjustment to Tetraphase’s inventory recorded in connection with the acquisition of Tetraphase (see Note 12). As of September 30, 2020 and December 31, 2019, total inventory is recorded net of inventory reserves of $0.2 million and $0.1 million, respectively.

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Software

 

$

733

 

 

$

733

 

Furniture and fixtures

 

 

598

 

 

 

2,598

 

Leasehold improvements

 

 

386

 

 

 

14,504

 

Computer hardware

 

 

310

 

 

 

1,296

 

Lab equipment

 

 

-

 

 

 

9,665

 

Total property and equipment, gross

 

 

2,027

 

 

 

28,796

 

Accumulated depreciation and amortization

 

 

(1,743

)

 

 

(10,407

)

Total property and equipment, net

 

$

284

 

 

$

18,389

 

The Company recorded a loss of approximately $12.9 million, net of $3.1 million of cash proceeds, in other income (expense), net, related to the disposal of tenant improvements and certain equipment in connection with the termination of the San Diego Lease. The $12.9 million loss is recorded in the consolidated statements of cash flows net of the gain from the termination of the San Diego Lease (see Note 6).

Intangible Assets, Net

Intangible assets, net consisted of the following (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Technology

 

$

14,000

 

 

$

-

 

Trade name

 

 

1,520

 

 

 

-

 

Total intangible assets, gross

 

 

15,520

 

 

 

-

 

Accumulated amortization

 

 

(259

)

 

 

-

 

Total intangible assets, net

 

$

15,261

 

 

$

-

 

The intangible assets were recorded in connection with the acquisition of Tetraphase (see Note 12).

Accrued Expenses

Accrued expenses consisted of the following (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Accrued interest expense

 

$

3,870

 

 

$

2,692

 

Accrued manufacturing costs

 

 

1,449

 

 

 

1,339

 

Accrued clinical study costs

 

 

426

 

 

 

3,496

 

Accrued other

 

 

1,938

 

 

 

1,785

 

Total accrued expenses

 

$

7,683

 

 

$

9,312

 

 

Other Noncurrent Liabilities

Other noncurrent liabilities consisted of the following (in thousands):

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Accrued interest expense

 

$

16,909

 

 

$

12,790

 

Fair value of CVRs (see Note 12)

 

 

2,610

 

 

 

-

 

Paycheck Protection Program loan

 

 

2,286

 

 

 

-

 

Total other noncurrent liabilities

 

$

21,805

 

 

$

12,790